{"id":"https://openalex.org/W2015536620","doi":"https://doi.org/10.1097/inf.0b013e31818c8d2c","title":"Tenofovir Use in Human Immunodeficiency Virus-1\u2013Infected Children in the United Kingdom and Ireland","display_name":"Tenofovir Use in Human Immunodeficiency Virus-1\u2013Infected Children in the United Kingdom and Ireland","publication_year":2009,"publication_date":"2009-03-01","ids":{"openalex":"https://openalex.org/W2015536620","doi":"https://doi.org/10.1097/inf.0b013e31818c8d2c","mag":"2015536620","pmid":"https://pubmed.ncbi.nlm.nih.gov/19209091"},"language":"en","primary_location":{"id":"doi:10.1097/inf.0b013e31818c8d2c","doi":"https://doi.org/10.1097/inf.0b013e31818c8d2c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/inf.0b013e31818c8d2c","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Infectious Disease Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111981753","display_name":"Andrew Riordan","orcid":"https://orcid.org/0000-0001-7244-870X","observed_orcids":["https://orcid.org/0000-0001-7244-870X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Andrew Riordan","raw_affiliation_strings":["Royal Liverpool Children's NHS Trust, Liverpool, England. Andrew.riordan@rlc.nhs.uk","Royal Liverpool Children's NHS Trust, Liverpool, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Liverpool Children's NHS Trust, Liverpool, England. Andrew.riordan@rlc.nhs.uk","institution_ids":[]},{"raw_affiliation_string":"Royal Liverpool Children's NHS Trust, Liverpool, England","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056504094","display_name":"Ali Judd","orcid":"https://orcid.org/0000-0003-3176-5295","observed_orcids":["https://orcid.org/0000-0003-3176-5295"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ali Judd","raw_affiliation_strings":["MRC Clinical Trials Unit, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit, London, England","institution_ids":["https://openalex.org/I4210091428"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110149826","display_name":"Katherine Boyd","orcid":"https://orcid.org/0009-0004-0210-1398","observed_orcids":["https://orcid.org/0009-0004-0210-1398"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Katherine Boyd","raw_affiliation_strings":["MRC Clinical Trials Unit, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit, London, England","institution_ids":["https://openalex.org/I4210091428"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079393008","display_name":"David Cliff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"David Cliff","raw_affiliation_strings":["Royal Liverpool Children's NHS Trust, Liverpool, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Liverpool Children's NHS Trust, Liverpool, England","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046307184","display_name":"Katia Doerholt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Katia Doerholt","raw_affiliation_strings":["MRC Clinical Trials Unit, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit, London, England","institution_ids":["https://openalex.org/I4210091428"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057611366","display_name":"Hermione Lyall","orcid":"https://orcid.org/0000-0002-1255-1833","observed_orcids":["https://orcid.org/0000-0002-1255-1833","https://orcid.org/0000-0001-6114-7215"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hermione Lyall","raw_affiliation_strings":["Imperial College NHS Trust, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College NHS Trust, London, England","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075885477","display_name":"Esse Menson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Esse Menson","raw_affiliation_strings":["Guy's and St Thomas\u2019 NHS Foundation Trust, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guy's and St Thomas\u2019 NHS Foundation Trust, London, England","institution_ids":["https://openalex.org/I200166805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047386035","display_name":"KARINA M. BUTLER","orcid":"https://orcid.org/0000-0002-7124-0883","observed_orcids":["https://orcid.org/0000-0002-7124-0883"]},"institutions":[{"id":"https://openalex.org/I3017411684","display_name":"Children's Health Ireland at Crumlin","ror":"https://ror.org/025qedy81","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I3017411684"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Karina Butler","raw_affiliation_strings":["Our Lady's Hospital for Sick Children, Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Our Lady's Hospital for Sick Children, Dublin, Ireland","institution_ids":["https://openalex.org/I3017411684"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030902925","display_name":"Diana M. Gibb","orcid":"https://orcid.org/0000-0002-9738-5490","observed_orcids":["https://orcid.org/0000-0002-9738-5490","https://orcid.org/0000-0002-4408-4336"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Di Gibb","raw_affiliation_strings":["MRC Clinical Trials Unit, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit, London, England","institution_ids":["https://openalex.org/I4210091428"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5079393008","https://openalex.org/A5111981753"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.8452,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.9613977,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"28","issue":"3","first_page":"204","last_page":"209"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":0.996999979019165},{"id":"https://openalex.org/keywords/pediatric-hiv-1-infection","display_name":"pediatric HIV-1 infection","score":0.8479999899864197},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7960000038146973},{"id":"https://openalex.org/keywords/dosing-errors","display_name":"dosing errors","score":0.8500000238418579},{"id":"https://openalex.org/keywords/didanosine","display_name":"didanosine","score":0.7860000133514404},{"id":"https://openalex.org/keywords/lopinavir-ritonavir","display_name":"lopinavir/ritonavir","score":0.9620000123977661},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.6470000147819519},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.8700000047683716},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.6819999814033508},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.8700000047683716},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.823201060295105},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.6708504557609558},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6700845956802368},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6652459502220154},{"id":"https://openalex.org/C2777447569","wikidata":"https://www.wikidata.org/wiki/Q422606","display_name":"Didanosine","level":5,"score":0.6390464901924133},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6352168917655945},{"id":"https://openalex.org/C2777182164","wikidata":"https://www.wikidata.org/wiki/Q422585","display_name":"Lopinavir","level":5,"score":0.6140407919883728},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.5490588545799255},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.47217005491256714},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42881259322166443},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.38246169686317444},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.32367628812789917},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26073288917541504},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.15462079644203186}],"mesh":[{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007494","descriptor_name":"Ireland","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010372","descriptor_name":"Pediatrics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/inf.0b013e31818c8d2c","doi":"https://doi.org/10.1097/inf.0b013e31818c8d2c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/inf.0b013e31818c8d2c","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Infectious Disease Journal","raw_type":"journal-article"},{"id":"pmid:19209091","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19209091","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Pediatric infectious disease journal","raw_type":"Clinical Trial"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1418000","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1418000/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PEDIATRIC INFECTIOUS DISEASE JOURNAL , 28 (3) pp. 204-209. (2009)","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W61078658","https://openalex.org/W172708961","https://openalex.org/W173136499","https://openalex.org/W1968454378","https://openalex.org/W1968603686","https://openalex.org/W1971310613","https://openalex.org/W2005617325","https://openalex.org/W2015673535","https://openalex.org/W2024949618","https://openalex.org/W2030111839","https://openalex.org/W2041839109","https://openalex.org/W2052688241","https://openalex.org/W2061278437","https://openalex.org/W2061577259","https://openalex.org/W2065776807","https://openalex.org/W2076790286","https://openalex.org/W2081469615","https://openalex.org/W2111980395","https://openalex.org/W2120721032","https://openalex.org/W2123983643","https://openalex.org/W2133262300","https://openalex.org/W2133804194","https://openalex.org/W2142982724","https://openalex.org/W2152470009","https://openalex.org/W2154532133","https://openalex.org/W2155676461","https://openalex.org/W2168296515","https://openalex.org/W4244215077","https://openalex.org/W6606956595","https://openalex.org/W6682978103"],"related_works":["https://openalex.org/W2006495612","https://openalex.org/W1978662604","https://openalex.org/W2007052999","https://openalex.org/W2046328812","https://openalex.org/W2255084257","https://openalex.org/W2168296515","https://openalex.org/W2270813523","https://openalex.org/W166029327","https://openalex.org/W2049188421","https://openalex.org/W2130271048"],"abstract_inverted_index":{"BACKGROUND:":[0],"Tenofovir":[1],"disoproxil":[2],"fumarate":[3],"(TDF)":[4],"is":[5,20],"neither":[6],"licensed":[7],"for":[8],"use":[9,52],"nor":[10],"extensively":[11],"studied":[12],"in":[13,30,43,55,61,74,85,206,214,230,244],"HIV-infected":[14],"children.":[15,31],"The":[16],"only":[17,227],"available":[18],"formulation":[19],"an":[21,240],"adult":[22],"tablet,":[23],"introducing":[24],"the":[25,51,62,75,104,112,138,141,152],"possibility":[26],"of":[27,53,58,87,122,140,151,160,172,208,257],"dosing":[28],"errors":[29],"TDF":[32,54,71,101,162,182,236],"interacts":[33],"with":[34,41,272],"other":[35],"antiretrovirals":[36],"and":[37,46,65,72,91,93,106,131,147,180,188,251,275],"has":[38],"been":[39],"associated":[40,271],"decline":[42],"renal":[44,193,268],"function":[45],"CD4":[47,215],"count.":[48],"We":[49],"describe":[50],"a":[56],"cohort":[57,80],"HIV-1-infected":[59],"children":[60,124,175,258],"United":[63],"Kingdom":[64],"Ireland.":[66],"METHODS:":[67],"Children":[68],"ever":[69],"prescribed":[70],"followed":[73],"Collaborative":[76],"HIV":[77],"Pediatric":[78],"Study":[79],"since":[81,169],"2001":[82],"were":[83,115,129,267],"included":[84],"analyses":[86],"dosing,":[88],"adverse":[89,97,178,261],"events,":[90],"virologic":[92],"immunologic":[94],"response.":[95],"Suspected":[96],"drug":[98,243],"reactions":[99],"to":[100,103,198,238],"reported":[102],"Medicines":[105],"Healthcare":[107],"products":[108],"Regulatory":[109],"Agency":[110],"during":[111],"same":[113],"time":[114],"also":[116],"reviewed.":[117],"RESULTS:":[118],"One":[119],"hundred":[120],"fifty-nine":[121],"1253":[123],"had":[125,132,192],"taken":[126],"TDF.":[127,211],"They":[128],"older":[130],"clinically":[133],"more":[134],"advanced":[135],"disease":[136],"than":[137],"rest":[139],"cohort.":[142],"Eighteen":[143],"percent":[144,159],"received":[145,149],">120%":[146],"37%":[148],"<80%":[150],"suggested":[153],"pediatric":[154,246],"dose":[155],"(8":[156],"mg/kg).":[157],"Thirty-seven":[158],"new":[161],"regimens":[163],"contained":[164],"didanosine":[165],"(ddI),":[166],"though":[167],"few":[168],"2005.":[170],"Twelve":[171],"159":[173],"(7.5%)":[174],"experienced":[176,259],"serious":[177,260],"events":[179,262],"stopped":[181],"permanently,":[183],"11":[184],"taking":[185,232,264],"concurrent":[186,233,273],"lopinavir-ritonavir,":[187],"10":[189],"ddI;":[190],"5":[191],"toxicity.":[194],"Viral":[195],"load":[196],"suppressed":[197],"<":[199],"or":[200],"=50":[201],"copies/mL":[202],"at":[203,217],"12":[204,218],"months":[205,219],"38%":[207],"those":[209,231],"starting":[210],"Median":[212],"increase":[213],"count":[216],"was":[220],"+110":[221],"cells/mL":[222,229],"(interquartile":[223],"range,":[224],"9-270),":[225],"but":[226],"3":[228],"ddI.":[234],"CONCLUSIONS:":[235],"seems":[237],"be":[239],"effective":[241],"antiretroviral":[242],"this":[245],"cohort,":[247],"although":[248],"considerable":[249],"underdosing":[250],"overdosing":[252],"occurs.":[253],"A":[254],"small":[255],"number":[256],"while":[263],"TDF;":[265],"half":[266],"toxicity,":[269],"most":[270],"ddI":[274],"lopinavir-ritonavir":[276],"use.":[277]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}